Tiblio
Sign Up

NMTC

Neuroone Medical Technologies Corp
NASDAQHEALTHCAREMEDICAL DEVICES

Key Statistics

Market Cap
$8.75M
P/E Ratio
—
EPS
$-0.99
Beta
0.76
52W High
$6.12
52W Low
$0.95
50-Day MA
$1.50
200-Day MA
$3.42
Dividend Yield
—
Profit Margin
-59.70%
Forward P/E
—
PEG Ratio
—

About Neuroone Medical Technologies Corp

NeuroOne Medical Technologies Corporation is a medical technology company. The company is headquartered in Eden Prairie, Minnesota.

Official WebsiteUSAFY End: September

Fundamentals

Revenue (TTM)$12.47M
Gross Profit (TTM)$2.87M
EBITDA$-7.66M
Operating Margin-122.90%
Return on Equity-124.70%
Return on Assets-58.10%
Revenue/Share (TTM)$1.47
Book Value$0.43
Price-to-Book3.25
Price-to-Sales (TTM)0.70
EV/Revenue1.096
EV/EBITDA-2.10
Quarterly Earnings Growth (YoY)0.00%
Quarterly Revenue Growth (YoY)16.30%
Shares Outstanding$9.11M
Float$6.26M
% Insiders25.44%
% Institutions22.45%

Historical Volatility

HV 10-Day
53.91%
HV 20-Day
95.05%
HV 30-Day
81.02%
HV 60-Day
90.72%
HV Rank
57.1%

Volatility is currently contracting

Analyst Ratings

Consensus ($7.27 target)
1
Strong Buy
2
Buy

Latest News

NeuroOne Reports Preliminary Fiscal Q4 Product Revenue Growth of 38.4%; Secures Record $4.5 Million Purchase Order

Preliminary Fiscal Q4 2026 Product Revenue of $3.8 Million Preliminary Full-Year Product Revenue Up 15.6% to $10.5 Million, at the Top of Guidance Range EDEN PRAIRIE, Minn., Oct. 05, 2026 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (“NeuroOne” or the “Company”), a medical technology company dedicated to transforming the surgical diagnosis and treatment of neurological disorders, today announced preliminary, unaudited product revenue for its fourth fiscal quarter and full fiscal year ended September 30, 2026, and provided an update on recent product orders.

GlobeNewsWire10/5/2026Neutral
NeuroOne® Expands U.S. Commercialization of FDA-Cleared OneRF® Trigeminal Nerve Ablation System with New Southern California Distribution Agreement

EDEN PRAIRIE, Minn., Sept. 17, 2026 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on transforming the surgical diagnosis and treatment of neurological disorders, today announced a new Southern California distribution agreement for its FDA-cleared OneRF® Trigeminal Nerve Ablation System.

GlobeNewsWire9/17/2026Neutral

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on NMTC and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More HEALTHCARE Stocks

LLYEli Lilly and CompanyJNJJohnson & JohnsonABBVAbbVie IncUNHUnitedHealth Group IncorporatedMRKMerck & Company IncNVSNovartis AG ADRAZNAstraZeneca PLCTMOThermo Fisher Scientific IncAMGNAmgen IncGILDGilead Sciences IncABTAbbott LaboratoriesNVONovo Nordisk A/S
View all HEALTHCARE stocks →
Data last updated: 10/17/2026